Brief: Leading Independent Proxy Advisory Firm Iss Recommends Sesen Bio Stockholders Vote “For” All Proposals At March 2 Special Meeting
16/02/2023 23:18
Feb 16 (Reuters) - Sesen Bio Inc SESN.O :
* LEADING INDEPENDENT PROXY ADVISORY FIRM ISS RECOMMENDS
SESEN BIO
STOCKHOLDERS VOTE “FOR” ALL PROPOSALS AT MARCH 2 SPECIAL MEETING
Source text for Eikon: ID:nBw6zXSTGa
Further company coverage: SESN.O
Recent news on Carisma Therapeutics
See all newsBrief: Carisma Therapeutics & Modernatx Amend Collaboration & And License Agreement - SEC Filing
Carisma Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Carisma Therapeutics Inc expected to post a loss of 9 cents a share - Earnings Preview
Brief: Carisma Therapeutics And Orthocellix Enter Into Definitive Merger Agreement
Carisma Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary